Table 1.
Dienogest | Leuprolide acetate | Test of significance | p value | |
---|---|---|---|---|
Age | 29.52 ± 3.32 | 29.77 ± 3.09 | t = − 0.601 | 0.548 |
Weight | 67.55 ± 6.65 | 67.19 ± 6.97 | t = 0.406 | 0.685 |
BMI | 25.03 ± 1.45 | 24.84 ± 1.47 | t = 0.991 | 0.323 |
VAS of pelvic pain | 59.27 ± 11.02 | 58.73 ± 11.01 | t = 0.343 | 0.732 |
VAS of back pain | 45.91 ± 3.33 | 46.68 ± 3.29 | t = − 1.358 | 0.177 |
VAS of dyspareunia | 36.53 ± 3.87 | 34.98 ± 4.96 | t = 1.859 | 0.066 |
Stage of endometriosis | ||||
I | 30 (24.8%) | 27 (22.3%) | X2 = 0.42 | 0.93 |
II | 36 (29.8%) | 39 (32.2%) | ||
III | 32 (26.4%) | 34 (28.1%) | ||
IV | 23 (19.0%) | 21 (17.4%) |